Health Care · Surgical & Medical Instruments & Apparatus

LNSR LENSAR, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 132035070 filings
Russell 2000

LNSR at a glance

LENSAR, Inc. (LNSR, SEC CIK 1320350) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 10, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), LENSAR, Inc. (LNSR) reported revenue of $51.7 million (up 12.4% from FY2024) and a net loss of $34.3 million. Diluted EPS was -$2.87.
  • As of September 30, 2026, 14 institutional investment managers tracked by SignalX reported holding LENSAR, Inc. (LNSR) shares worth $6.6 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by O'Farrell Elizabeth G. on November 18, 2026 of 10,961 shares at $4.97 per share.
  • In the last 90 days, LNSR insiders reported 0 open-market purchases ($0) and 2 open-market sales ($170K) on Form 4, a net sale of $170K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$51.7M
+12.4% vs prior year
Insiders · 90 days
0 buys · 2 sells
Net −$170K
13F holders
14 funds
$6.6M · −1 vs prior quarter
Latest 8-K
Nov 10, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New legal risk, triggered by terminated Alcon merger: additional shareholder demands or litigation could increase costs and result in damages
  • Most material update, merger termination: distributor activity declined after announcement, with further production and inventory impacts expected
  • Regulatory risk, EU Medical Devices Regulation: CE-mark compliance required before selling products in EU member states
  • Competitive risk, Bausch + Lomb SeeLyra™: second-generation femtosecond laser expected to launch in the second half of 2026
  • Financial risk, credit facility: $3.0 million minimum cash requirement until 2026 EBITDA covenant compliance

Management Discussion & Analysis

  • Revenue $14.1M, down 1% YoY from $14.3M, driven by lower System sales offset by higher procedure volume
  • Product revenue $10.7M, down 6%; procedure revenue $9.2M, up 17% from $7.8M
  • Gross margin 57.8% vs 42.1% YoY, based on revenue and cost of revenue
  • Net loss $4.7M vs $3.7M; Adjusted EBITDA $1.7M vs $(0.3)M
  • Operating cash outflow $5.3M vs $15.4M; $10.0M revolving facility established, undrawn at quarter-end; tariff inflation remains a headwind

AI summary of the LNSR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 10, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal quarter ended September 30, 2026 results announced by LENSAR
  • Press release contains the financial figures and management commentary

Item EX-99.1: Item EX-99.1

  • Q3 revenue $14.1M, down 1% year over year, reflecting lower system sales and seasonal purchasing patterns
  • Recurring revenue $12.6M, up 17%, reaching 89% of revenue versus 75% a year earlier
Filed Aug 13, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal quarter ended June 30, 2026 results announced August 13, 2026
  • Full financial results and management commentary furnished in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q2 revenue $16.5M, up 18%, with recurring revenue $13.7M, up 20%, strengthening the recurring-revenue model
  • 10 ALLY placements, 13-system backlog, and 215 ALLY systems installed, up 30% year over year
Filed Aug 10, 2026Full analysis →

Item 5.07: Submission of Matters to a Vote of Security Holders

  • 90.53% voting participation, providing strong shareholder representation at the August 4 annual meeting
  • Three Class III directors elected through 2029, preserving board continuity

AI summaries of LNSR 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for LNSR

Don't miss the next LNSR filing

  • Alerts as it files. A push when LNSR files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut LNSR, by share count.
  • Ask anything. An AI agent that reads every LNSR filing and answers with sources.

LNSR alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
O'Farrell Elizabeth G.MNov 18, 2026-
O'Farrell Elizabeth G.SellNov 18, 2026$4.97
O'Farrell Elizabeth G.MNov 18, 2026$3.23
O'Farrell Elizabeth G.MNov 17, 2026$3.23
O'Farrell Elizabeth G.MNov 17, 2026-
O'Farrell Elizabeth G.SellNov 17, 2026$5.20
Winer Gary MANov 11, 2026$4.53
WEISNER AIMEE SAJun 3, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$35.7M$46.0M$51.7M
Operating Income--$10.7M-$24.6M
Net Income-$14.4M-$31.4M-$34.3M
Op. Margin--23.2%-47.6%
Net Margin-40.3%-68.3%-66.4%
Balance Sheet
Total Assets-$66.3M$71.4M
Equity-$4.9M-$26.0M
ROE--645.9%131.7%
Per Share
EPS$-1.31$-2.73$-2.87
Cash Flow
Operating CF--$2.3M-$14.8M
CapEx$236K$156K$83K

Source: XBRL data in LENSAR, Inc. (LNSR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate LNSR share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
LNSR shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202614$6.6M
Q2 202615$6.2M
Q1 202615$10.1M
Q4 202513$20.3M
Q3 202515$20.9M
Q2 202517$21.6M
Q1 202513$21.4M
Q4 20247$13.4M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 109 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

LNSR filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 19, 2026--
4Nov 13, 2026--
10-QNov 10, 2026Analysis
8-KNov 10, 2026Analysis-
10-QAug 13, 2026Analysis
8-KAug 13, 2026Analysis-
8-KAug 10, 2026Analysis-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
8-KMay 29, 2026Analysis
4May 8, 2026-
8-KMay 8, 2026Analysis
4May 8, 2026-
10-QMay 8, 2026Analysis
4May 8, 2026-
4May 8, 2026-
8-KApr 15, 2026Analysis-

Related Health Care companies

All Health Care →

LNSR SEC filings: frequently asked questions

Are LNSR insiders buying or selling?

In the last 90 days, LENSAR, Inc. (LNSR) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $169,989 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold LNSR stock?

As of September 30, 2026, the largest LENSAR, Inc. (LNSR) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($2.7 million), BlackRock ($1.1 million), Millennium Management ($581,000), Dimensional Fund Advisors ($480,000), State Street Corp ($474,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was LNSR's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), LENSAR, Inc. (LNSR) reported revenue of $51.7 million (up 12.4% from FY2024) and a net loss of $34.3 million. Diluted EPS was -$2.87. The figures come from the XBRL data in the 10-K.

What did LNSR report in its latest 8-K?

LENSAR, Inc. (LNSR) filed an 8-K on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal quarter ended September 30, 2026 results announced by LENSAR.

What are the latest LNSR SEC filings?

LENSAR, Inc. (LNSR) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 10, 2026 and a Form 4 insider filing on November 19, 2026.

What is LNSR's SEC CIK number?

LENSAR, Inc. (LNSR)'s SEC Central Index Key (CIK) is 1320350. EDGAR lists every LNSR filing under that number.

Ask anything about LNSR

The research agent reads LNSR's filings, financials, insider trades and 13F holders, then answers with sources.